The next generation of EGFR inhibitors: a patenting perspective of PROTACs based EGFR degraders

.

Source: Expert Opinion on Therapeutic Patents - October 24, 2023 Category: Drugs & Pharmacology Authors: Pengyun LiBingkun LiNing YangTingting XuZhibing ZhengNational Engineering Research Center for Strategic Drugs, Beijing Institute of Pharmacology and Toxicology, Beijing, China Source Type: research